Active Stock Movers

Kim Kahn reviews Birkenstock's tariff-driven slump, Lilly's obesity drug trial, and Accenture's soft guidance.

Play episode from 02:44

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!